PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat
- PMID: 12782412
- DOI: 10.1016/s0303-7207(03)00008-x
PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat
Abstract
Protein tyrosine phosphatases are important regulators of insulin signal transduction. Our studies have shown that in insulin resistant and diabetic ob/ob and db/db mice, reducing the levels of protein tyrosine phosphatase 1B (PTP1B) protein by treatment with a PTP1B antisense oligonucleotide resulted in improved insulin sensitivity and normalized plasma glucose levels. The mechanism by which PTP1B inhibition improves insulin sensitivity is not fully understood. We have used microarray analysis to compare gene expression changes in adipose tissue, liver and muscle of PTP1B antisense-treated ob/ob mice. Our results show that treatment with PTP1B antisense resulted in the downregulation of genes involved in lipogenesis in both fat and liver, and a downregulation of genes involved in adipocyte differentiation in fat, suggesting that PTP1B antisense acts through a different mechanism than thiazolidinedione (TZD) treatment. In summary, microarray results suggest that reduction of PTP1B may alleviate hyperglycemia and enhance insulin sensitivity by a different mechanism than TZD treatment.
Similar articles
-
Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis.Diabetes. 2002 Aug;51(8):2405-11. doi: 10.2337/diabetes.51.8.2405. Diabetes. 2002. PMID: 12145151
-
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice.Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11357-62. doi: 10.1073/pnas.142298199. Epub 2002 Aug 8. Proc Natl Acad Sci U S A. 2002. PMID: 12169659 Free PMC article.
-
Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.Diabetes. 2003 Jan;52(1):21-8. doi: 10.2337/diabetes.52.1.21. Diabetes. 2003. PMID: 12502489
-
Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic _target for type 2 diabetes mellitus, obesity and related states of insulin resistance.Curr Drug _targets Immune Endocr Metabol Disord. 2001 Nov;1(3):265-75. doi: 10.2174/1568008013341163. Curr Drug _targets Immune Endocr Metabol Disord. 2001. PMID: 12477292 Review.
-
Protein tyrosine phosphatase 1B as a _target for the treatment of impaired glucose tolerance and type II diabetes.Curr Opin Investig Drugs. 2002 Nov;3(11):1608-16. Curr Opin Investig Drugs. 2002. PMID: 12476961 Review.
Cited by
-
Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B.Mol Cell Biol. 2007 Nov;27(21):7727-34. doi: 10.1128/MCB.00959-07. Epub 2007 Aug 27. Mol Cell Biol. 2007. PMID: 17724080 Free PMC article.
-
Protein tyrosine phosphatase 1B in metabolic diseases and drug development.Nat Rev Endocrinol. 2024 Jun;20(6):366-378. doi: 10.1038/s41574-024-00965-1. Epub 2024 Mar 22. Nat Rev Endocrinol. 2024. PMID: 38519567 Review.
-
Liver-specific deletion of protein tyrosine phosphatase (PTP) 1B improves obesity- and pharmacologically induced endoplasmic reticulum stress.Biochem J. 2011 Sep 1;438(2):369-78. doi: 10.1042/BJ20110373. Biochem J. 2011. PMID: 21605081 Free PMC article.
-
The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance.Biomolecules. 2019 Jul 17;9(7):286. doi: 10.3390/biom9070286. Biomolecules. 2019. PMID: 31319588 Free PMC article. Review.
-
Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics.Front Cardiovasc Med. 2024 Aug 22;11:1445739. doi: 10.3389/fcvm.2024.1445739. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39238503 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
